Ticker
BIAFCompany Name
BIOAFFINITY TECHNOLOGIES INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 7.68M | $ 958K | 12.47% |
3/31/2025 | $ 8.81M | $ 1.03M | 11.72% |
12/31/2024 | $ 9.36M | $ 989.68K | 10.57% |
9/30/2024 | $ 9.37M | $ 990.1K | 10.57% |
6/30/2024 | $ 7.32M | $ 990.86K | 13.54% |
3/31/2024 | $ 4.94M | $ 874.92K | 17.72% |
12/31/2023 | $ 2.53M | $ 748.82K | 29.57% |
9/30/2023 | $ 321.49K | $ 551.16K | 171.44% |
6/30/2023 | $ 24.16K | $ 443.73K | 1837% |
3/31/2023 | $ 5.72K | $ 300.16K | 5244.77% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for BIOAFFINITY TECHNOLOGIES INC is calculated as follows: SB Comp. [ $ 43.01K ] / Revenues [ $ 0 ]
(=) SB Comp % [ 0% ]
Minimum
Sep 30, 2024
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 2.98K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |